BARCLAYS PLC - BLACK DIAMOND THERAPEUTICS I ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$925
+47.3%
322,246
+159.1%
0.00%
Q2 2023$628
+1597.3%
124,351
+542.6%
0.00%
Q1 2023$37
+5.7%
19,3510.0%0.00%
Q4 2022$35
-99.9%
19,351
-7.6%
0.00%
Q3 2022$35,000
-35.2%
20,935
-4.8%
0.00%
Q2 2022$54,000
-26.0%
21,992
-16.6%
0.00%
Q1 2022$73,00026,3800.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$104,289,0004.42%
Boxer Capital, LLC 2,014,858$60,909,0002.10%
RA Capital Management 2,589,904$78,293,0001.43%
Artal Group S.A. 1,521,517$45,995,0001.12%
Ikarian Capital, LLC 358,941$10,851,0000.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$24,260,0000.59%
Bellevue Group AG 1,403,000$42,413,0000.59%
Logos Global Management LP 123,465$3,732,0000.48%
Casdin Capital, LLC 289,395$8,748,0000.39%
HighVista Strategies LLC 16,391$496,0000.36%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders